Armando Sena
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Oral Contraceptives Interact with Adiposity-Associated Markers in Patients with Multiple Sclerosis.
Journal: Journal of clinical medicine
Published: November 26, 2023
Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis.
Journal: Frontiers in molecular neuroscience
Published: October 22, 2022
Serum Lipoprotein Profile Is Associated With Protective Effects of Oral Contraceptive Use on Multiple Sclerosis Severity: A Cross-Sectional Study.
Journal: Frontiers in neurology
Published: October 25, 2018
Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: April 28, 2018
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Journal: Neurology
Published: May 25, 2016
Oral contraceptive use and clinical outcomes in patients with multiple sclerosis.
Journal: Journal of the neurological sciences
Published: November 22, 2011
Influence of apolipoprotein E plasma levels and tobacco smoking on the induction of neutralising antibodies to interferon-beta.
Journal: Journal of neurology
Published: February 15, 2010
Interferon beta therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 25, 2008
Showing 1-9 of 9
Last Updated: 09/26/2026